References
- Park MA, Zhang G, Martin AP, Hamed H, Mitchell C, Hylemon PB, et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol Ther 2008; 7:1648 - 62; http://dx.doi.org/10.4161/cbt.7.10.6623; PMID: 18787411
- Chen KF, Chen HL, Tai WT, Feng WC, Hsu CH, Chen PJ, et al. Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J Pharmacol Exp Ther 2011; 337:155 - 61; http://dx.doi.org/10.1124/jpet.110.175786; PMID: 21205925
- Brózik A, Hegedus C, Erdei Z, Hegedus T, Ozvegy-Laczka C, Szakacs G, et al. Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?. Expert Opin Drug Metab Toxicol 2011; 7:623 - 42; http://dx.doi.org/10.1517/17425255.2011.562892; PMID: 21410427
- Agarwal S, Sane R, Ohlfest JR, Elmquist WF. The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain. J Pharmacol Exp Ther 2011; 336:223 - 33; http://dx.doi.org/10.1124/jpet.110.175034; PMID: 20952483
- Weichert N, Kaltenborn E, Hector A, Woischnik M, Schams A, Holzinger A, et al. Some ABCA3 mutations elevate ER stress and initiate apoptosis of lung epithelial cells. Respir Res 2011; 12:4; http://dx.doi.org/10.1186/1465-9921-12-4; PMID: 21214890
- Chiou JF, Tai CJ, Huang MT, Wei PL, Wang YH, An J, et al. Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma. Ann Surg Oncol 2010; 17:603 - 12; http://dx.doi.org/10.1245/s10434-009-0718-8; PMID: 19830497
- Ni M, Zhang Y, Lee AS. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochem J 2011; 434:181 - 8; http://dx.doi.org/10.1042/BJ20101569; PMID: 21309747